Cipla Ltd. announced that its subsidiary Cipla (EU) Limited has agreed to acquire the remaining 6.9% equity interest in Cipla (Jiangsu) Pharmaceuticals Co., Ltd., making it a wholly owned subsidiary, thereby enhancing its control in the Chinese market.